Pfizer Manufacturing Deutschland GmbH has recalled several lots of Atorvastatin calcium Film-Coated Tablets, the generic version of the cholesterol medication Lipitor, due to microbial contamination. Approximately 31 million tablets in various strengths (20 mg, 40 mg, and 80 mg) are affected by this recall. While these specific products were manufactured for export and were not distributed within the United States or its territories, consumers who may have obtained these medications abroad should be aware of the potential health risks. If you are using this medication, contact your healthcare provider or pharmacist for guidance and to obtain a safe replacement.
The tablets are contaminated with microorganisms, which can lead to infections or other adverse health effects, particularly in individuals with weakened immune systems or underlying health conditions.
Contact healthcare provider and return product to pharmacy.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.